The device’s 510(k) application is currently under review by the FDA for market clearance. Pursuant to the agreement, Alphatec Spine will pay an upfront fee over the next 12 months and has agreed to certain minimum purchase commitments.
More Articles on Orthopedic Devices:
10 Orthopedic Device Company Acquisitions
ECA Medical Launches Model 900 Series
Judge: NuVasive May Review Documents to Confirm Employee Poaching By Lanx
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
